{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:26:23Z","timestamp":1789241183635,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea","award":["A103017"],"award-info":[{"award-number":["A103017"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea [NRF]","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korea government [MEST]","award":["2011-0028962"],"award-info":[{"award-number":["2011-0028962"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.intimp.2013.01.005","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T12:03:35Z","timestamp":1358856215000},"page":"424-432","source":"Crossref","is-referenced-by-count":26,"title":["Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC\/Nga mice"],"prefix":"10.1016","volume":"15","author":[{"given":"Chang-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Seok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Ah.","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.01.005_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4370","article-title":"Systematic review of treatments for atopic eczema","volume":"4","author":"Hoare","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.intimp.2013.01.005_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2013.01.005_bb0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI5669","article-title":"Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis","volume":"103","author":"Spergel","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.01.005_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2500\/aap.2006.27.2887","article-title":"Immune dysregulation in atopic dermatitis","volume":"27","author":"Miraglia del Giudice","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.intimp.2013.01.005_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.clindermatol.2011.08.023","article-title":"Abnormal epidermal barrier in the pathogenesis of atopic dermatitis","volume":"30","author":"Wolf","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2230.1990.tb02086.x","article-title":"Blood eosinophilia in atopic dermatitis","volume":"15","author":"Uehara","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2011.05.005","article-title":"Autoreactive CD4(+) T cells in patients with atopic dermatitis","volume":"128","author":"James","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2005.09.004","article-title":"T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases","volume":"116","author":"Akdis","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4049\/jimmunol.178.1.584","article-title":"Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC\/Nga mice, a model of human atopic dermatitis","volume":"178","author":"Inoue","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-3083.2003.01313.x","article-title":"Immunobiological effects of glucosamine in vitro","volume":"58","author":"Forchhammer","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-3083.2011.02526.x","article-title":"Glucosamine improved atopic dermatitis-like skin lesions in NC\/Nga mice by inhibition of Th2 cell development","volume":"73","author":"Kim","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/ACI.0b013e32833e16e4","article-title":"Atopic keratoconjunctivitis and atopic dermatitis","volume":"10","author":"Guglielmetti","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report","volume":"118","author":"Akdis","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/00015555-0327","article-title":"Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B","volume":"88","author":"Campione","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3349\/ymj.2012.53.1.158","article-title":"Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin","volume":"53","author":"Nahm","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.intimp.2013.01.005_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/jid.2008.106","article-title":"Animal models of atopic dermatitis","volume":"129","author":"Jin","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-3083.2011.02659.x","article-title":"Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"75","author":"Kim","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000053599","article-title":"NC\/Nga mice: a mouse model for atopic dermatitis","volume":"120","author":"Suto","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"issue":"2 Suppl. 2","key":"10.1016\/j.intimp.2013.01.005_bb0100","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.jaci.2009.05.039","article-title":"Allergic skin diseases","volume":"125","author":"Fonacier","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0105","first-page":"387","article-title":"New and emerging trends in the treatment of atopic dermatitis","volume":"2","author":"Gelbard","year":"2008","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.intimp.2013.01.005_bb0110","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaad.2008.09.034","article-title":"Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study","volume":"60","author":"Kubota","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1346-8138.2004.tb00548.x","article-title":"Intermittent topical corticosteroid\/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid\/emollient sequential therapy in patients with atopic dermatitis","volume":"31","author":"Nakahara","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0120","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0952-7915(92)90064-L","article-title":"Regulation of isotype switching","volume":"4","author":"Vercelli","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/intimm\/9.3.461","article-title":"Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC\/Nga mice","volume":"9","author":"Matsuda","year":"1997","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1067\/mai.2001.112601","article-title":"CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis","volume":"107","author":"Nakatani","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1172\/JCI0214097","article-title":"CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation","volume":"109","author":"Ma","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.01.005_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20051745","article-title":"Thymic stromal lymphopoietin: master switch for allergic inflammation","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.01.005_bb0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaci.2007.06.004","article-title":"Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation","volume":"120","author":"Liu","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4049\/jimmunol.173.1.267","article-title":"Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells","volume":"173","author":"Stassen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0160","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1378\/chest.06-2434","article-title":"Regulatory T, cells in allergy and asthma","volume":"132","author":"Larch\u00e9","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2013.01.005_bb0165","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1398-9995.2009.02054.x","article-title":"Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis","volume":"64","author":"Brandt","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2013.01.005_bb0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI57416","article-title":"Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases","volume":"122","author":"Kubo","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.01.005_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat Immunol"},{"issue":"3 Suppl. 2","key":"10.1016\/j.intimp.2013.01.005_bb0180","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"Howell","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2013.01.005_bb0190","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1007\/s00403-002-0377-0","article-title":"Aberrant suprabasal P-cadherin expression in acanthotic but not psoriatic thickened epidermis","volume":"295","author":"Wakita","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.intimp.2013.01.005_bb0195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.rvsc.2012.06.005","article-title":"Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis","volume":"93","author":"Theerawatanasirikul","year":"2012","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.intimp.2013.01.005_bb0200","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/jid.2011.412","article-title":"Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis","volume":"132","author":"Mantel","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2013.01.005_bb0205","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1185\/030079908X280419","article-title":"Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas","volume":"24","author":"Draelos","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.intimp.2013.01.005_bb0210","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2009.03.032","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"123","author":"Jensen","year":"2009","journal-title":"J Allergy Clin Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T13:40:24Z","timestamp":1562593224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1567576913000192"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.01.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}